Drug delivery systems based on elastin-like polypeptides are currently being applied synergistically with hyperthermia technology, and these drug delivery systems increase the efficacy of drug targeting and minimize the side effects of administration especially for cancer treatment. This evidence concerns the gene ELN and cancer.